Literature DB >> 21211844

High-resolution in vivo imaging in achromatopsia.

Mervyn G Thomas1, Anil Kumar, Susanne Kohl, Frank A Proudlock, Irene Gottlob.   

Abstract

PURPOSE: To characterize the retinal changes in patients with achromatopsia using an ultrahigh-resolution (UHR) spectral-domain optical coherence tomography (OCT) to examine how human achromatopsia corresponds to its animal model.
DESIGN: Comparative case series. PARTICIPANTS AND CONTROLS: Ultrahigh-resolution OCT (Copernicus; OPTOPOL Technology S.A., Zawiercie, Poland; 3-μm axial resolution) was used to obtain scans from 13 patients (26 eyes) with achromatopsia and from 20 controls (40 eyes).
METHODS: A 3-dimensional scan program (743×75; A×B scan) sampling a 7×7-mm retinal area centered at the fovea was used to obtain tomograms of the fovea. Individual B-scans at the fovea were exported and analyzed using ImageJ (Wayne Rasband, National Institute of Health) for reflectance profiles and morphologic abnormalities. MAIN OUTCOME MEASURES: Gross morphologic changes in OCT were characterized. Specifically, inner segment and outer segment (IS/OS) junction and cone outer segment tip (COST) disruption was noted. Using the reflectance profiles, foveal depth, thickness of the outer nuclear layer (ONL), and retinal thickness (RT) were measured.
RESULTS: A characteristic so-called punched out hyporeflective zone (HRZ) was noted in 7 of 13 patients; this was age-dependent (P = 0.001). The area of the HRZ was asymmetric with the nasal area being significantly greater than the temporal area (P = 0.002). In all patients, there was disruption of the IS/OS junction at the foveal or parafoveal regions, or both. Five of 13 patients also had a disrupted COST reflectivity. There was significant (P = 1.1×10(-6)) ONL thinning in the achromats compared with controls, which was age-dependent (P = 0.0002). Foveal maldevelopment was seen in 9 of 13 patients. The achromats also had a significantly reduced foveal depth (P = 7.7×10(-6)) and RT (P = 1.46×10(-9)) compared with controls.
CONCLUSIONS: A range of signs in achromatopsia are described that can be detected using UHR OCT. The IS/OS junction and COST reflectivity disruption and presence of HRZ and ONL thinning are signs of cone photoreceptor degeneration. The latter 2 are age-dependent, which suggests that achromatopsia is a progressive disorder. In addition, foveal maldevelopment is described; this represents a fetal developmental defect linked to cone photoreceptor degeneration.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21211844     DOI: 10.1016/j.ophtha.2010.08.053

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  44 in total

1.  Macular optical coherence tomography in patients with unilateral optic nerve hypoplasia.

Authors:  Javaneh Abbasian; Norman Blair; Mahnaz Shahidi; Gui-Shuaung Ying; Jiayan Huang; Lawrence Kaufman; Michael Blair
Journal:  J AAPOS       Date:  2015-02       Impact factor: 1.220

2.  Differences in ocular findings in two siblings: one with complete and other with incomplete achromatopsia.

Authors:  Shinji Ueno; Ayami Nakanishi; Akira Sayo; Taro Kominami; Yasuki Ito; Takaaki Hayashi; Kazushige Tsunoda; Takeshi Iwata; Hiroko Terasaki
Journal:  Doc Ophthalmol       Date:  2017-02-14       Impact factor: 2.379

3.  Phenotypic characteristics including in vivo cone photoreceptor mosaic in KCNV2-related "cone dystrophy with supernormal rod electroretinogram".

Authors:  Ajoy Vincent; Tom Wright; Yaiza Garcia-Sanchez; Marsha Kisilak; Melanie Campbell; Carol Westall; Elise Héon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-30       Impact factor: 4.799

Review 4.  Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.

Authors:  Pasqualina Colella; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

5.  Spectral-domain optical coherence tomography staging and autofluorescence imaging in achromatopsia.

Authors:  Jonathan P Greenberg; Jerome Sherman; Sandrine A Zweifel; Royce W S Chen; Tobias Duncker; Susanne Kohl; Britta Baumann; Bernd Wissinger; Lawrence A Yannuzzi; Stephen H Tsang
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

6.  Genotype-dependent variability in residual cone structure in achromatopsia: toward developing metrics for assessing cone health.

Authors:  Adam M Dubis; Robert F Cooper; Jonathan Aboshiha; Christopher S Langlo; Venki Sundaram; Benjamin Liu; Frederick Collison; Gerald A Fishman; Anthony T Moore; Andrew R Webster; Alfredo Dubra; Joseph Carroll; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-02       Impact factor: 4.799

7.  Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.

Authors:  Paul Yang; Keith V Michaels; Robert J Courtney; Yuquan Wen; Daniel A Greninger; Leah Reznick; Daniel J Karr; Lorri B Wilson; Richard G Weleber; Mark E Pennesi
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

8.  Long-term follow-up of two patients with oligocone trichromacy.

Authors:  Vasily Smirnov; Isabelle Drumare; Ikram Bouacha; Bernard Puech; Sabine Defoort-Dhellemmes
Journal:  Doc Ophthalmol       Date:  2015-07-03       Impact factor: 2.379

Review 9.  Retinal dystrophies and gene therapy.

Authors:  Venki Sundaram; Anthony T Moore; Robin R Ali; James W Bainbridge
Journal:  Eur J Pediatr       Date:  2011-11-15       Impact factor: 3.183

10.  Measurement of macular thickness with optical coherence tomography: impact of using a paediatric reference database and analysis of interocular symmetry.

Authors:  Alicia Muñoz-Gallego; José L Torres-Peña; Martín Rodríguez-Salgado; Ana Ortueta-Olartecoechea; Cristina López-López; Javier De la Cruz; Pilar Tejada-Palacios
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.